| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $254.4M | -5.3% |
| R&D Expense | $85.8M | +13.8% |
| SG&A Expense | $136.5M | +10.0% |
| Operating Income | $6.3M | -85.0% |
| Pre-tax Income | $11.3M | -73.3% |
| Income Tax | $5.0M | -45.5% |
| Net Income | $6.3M | -81.1% |
| EPS (Basic) | $0.11 | -81.7% |
| EPS (Diluted) | $0.11 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $135.0M | +159.3% |
| Accounts Receivable | $33.5M | +3.2% |
| Inventory | $1.2M | +16.5% |
| Current Assets | $519.3M | +8.6% |
| Total Assets | $634.2M | +6.8% |
| Current Liabilities | $91.4M | +22.9% |
| Total Liabilities | $107.0M | +20.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $32.0M | -50.2% |
| Capital Expenditures | $679K | +23.0% |
| Investing Cash Flow | $49.9M | +165.1% |
| Financing Cash Flow | $734K | -79.3% |
| Free Cash Flow | $31.3M | -50.8% |
| -81.0% |
| Stockholders' Equity |
| $527.2M |
| +4.4% |